Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy
- Author
- Rani Soenen (UGent) , Evelyn Meulewaeter, Lynda Grine (UGent) , Nathalie Van den Berghe, Els Brouwers, Reinhart Speeckaert (UGent) , Sven Lanssens, Linda Temmerman, Jo Lambert (UGent) and Ann Gils
- Organization
- Project
Downloads
-
Speeckaert defining a minimal.pdf
- full text (Published version)
- |
- open access
- |
- |
- 415.69 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8714260
- MLA
- Soenen, Rani, et al. “Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis : A Step toward Personalized Therapy.” JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 139, no. 10, 2019, pp. 2232–35, doi:10.1016/j.jid.2019.04.012.
- APA
- Soenen, R., Meulewaeter, E., Grine, L., Van den Berghe, N., Brouwers, E., Speeckaert, R., … Gils, A. (2019). Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(10), 2232–2235. https://doi.org/10.1016/j.jid.2019.04.012
- Chicago author-date
- Soenen, Rani, Evelyn Meulewaeter, Lynda Grine, Nathalie Van den Berghe, Els Brouwers, Reinhart Speeckaert, Sven Lanssens, Linda Temmerman, Jo Lambert, and Ann Gils. 2019. “Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis : A Step toward Personalized Therapy.” JOURNAL OF INVESTIGATIVE DERMATOLOGY 139 (10): 2232–35. https://doi.org/10.1016/j.jid.2019.04.012.
- Chicago author-date (all authors)
- Soenen, Rani, Evelyn Meulewaeter, Lynda Grine, Nathalie Van den Berghe, Els Brouwers, Reinhart Speeckaert, Sven Lanssens, Linda Temmerman, Jo Lambert, and Ann Gils. 2019. “Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis : A Step toward Personalized Therapy.” JOURNAL OF INVESTIGATIVE DERMATOLOGY 139 (10): 2232–2235. doi:10.1016/j.jid.2019.04.012.
- Vancouver
- 1.Soenen R, Meulewaeter E, Grine L, Van den Berghe N, Brouwers E, Speeckaert R, et al. Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2019;139(10):2232–5.
- IEEE
- [1]R. Soenen et al., “Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy,” JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 139, no. 10, pp. 2232–2235, 2019.
@article{8714260,
author = {{Soenen, Rani and Meulewaeter, Evelyn and Grine, Lynda and Van den Berghe, Nathalie and Brouwers, Els and Speeckaert, Reinhart and Lanssens, Sven and Temmerman, Linda and Lambert, Jo and Gils, Ann}},
issn = {{0022-202X}},
journal = {{JOURNAL OF INVESTIGATIVE DERMATOLOGY}},
language = {{eng}},
number = {{10}},
pages = {{2232--2235}},
title = {{Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy}},
url = {{http://doi.org/10.1016/j.jid.2019.04.012}},
volume = {{139}},
year = {{2019}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: